Immune cell profile of tumors from patients with metastatic (met) HER2+breast cancer (BC) with < 30 months overall survival (OS)

Immune cell profile of tumors from patients with metastatic (met) HER2+breast cancer (BC) with < 30 months overall survival (OS) | AMiner

Immune cell profile of tumors from patients with metastatic (met) HER2+breast cancer (BC) with &lt; 30 months overall survival (OS)